Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | CPA1 | P15085 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.32 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6056700 | 1.00 | RNPEP (0.41) | RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2 | |
| Water SCHEMBL27284531 | 0.98 | RNPEP (0.40) | RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2 | |
| SCHEMBL27747260 | 0.86 | PLA2G2A (0.34) | RNPEPSLC7A5SLC1A3SLC1A2MAPT | |
| SCHEMBL11158578 | 0.86 | CYP3A4 (0.31) | LMNAMAPT | |
| SCHEMBL28822953 | 0.85 | RNPEP (0.31) | RNPEPSLC7A5 | |
| Leucine SCHEMBL15689481 | 0.85 | SLC7A5 (0.56) | RNPEPSLC7A5SLC1A3SLC1A2 | |
| Ammonia Solution, Strong SCHEMBL27843508 | 0.85 | PLA2G2A (0.33) | RNPEPSLC7A5MAPT | |
| SCHEMBL12485048 | 0.83 | GSR (0.40) | RNPEPSLC7A5SLC1A3SLC1A2CACNA2D1 | |
| SCHEMBL7953742 | 0.80 | — | — | |
| SCHEMBL27693374 | 0.80 | ACE (0.43) | ALDH1A1CPA1MEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11981753-B2 | Peptide compound and application thereof, and composition containing peptide compound | SHANGPHARMA INNOVATION INC. (US) | 2024-05-14 | — | — | US | disclosed |
| CN-116813705-A | Peptide compound, application thereof and composition containing peptide compound | 凯惠科技发展(上海)有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-109206481-B | Peptide compound, application thereof and composition containing peptide compound | 尚华医药科技(江西)有限公司 | 2023-08-18 | — | — | CN | disclosed |
| US-20230159453-A1 | INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | COCRYSTAL PHARMA, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230150933-A1 | BROAD SPECTRUM ANTIVIRALS AGAINST CORONAVIRUS | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2023-05-18 | — | — | US | disclosed |
| EP-4132944-A1 | INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | Cocrystal Pharma, Inc. (US) | 2023-02-15 | — | — | EP | disclosed |
| EP-4126816-A1 | BROAD SPECTRUM ANTIVIRALS AGAINST CORONAVIRUS | Kansas State University Research Foundation (US) | 2023-02-08 | — | — | EP | disclosed |
| CN-115698035-A | Inhibitors of norovirus and coronavirus replication | 共晶制药公司 | 2023-02-03 | — | — | CN | disclosed |
| WO-2021202460-A1 | BROAD SPECTRUM ANTIVIRALS AGAINST CORONAVIRUS | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2021-10-07 | — | — | WO | disclosed |
| US-20200172575-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2020-06-04 | — | — | US | disclosed |
| CN-1261276-A | Protease inhibitors | SMITHKLINE BEECHAM CORP (US) | 2000-07-26 | — | — | CN | disclosed |
| WO-2000035885-A1 | CYCLIC HYDRAZINE DERIVATIVES AS TNF-ALPHA INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | disclosed |
| CN-1255119-A | Protease inhibitors | SMITHKLINE BEECHAM CORP (US) | 2000-05-31 | — | — | CN | disclosed |
| CN-1195343-A | Piperazine derivatives and use of same | SENJU PHARMA CO (JP) | 1998-10-07 | — | — | CN | disclosed |
| CN-1163145-A | Inhibiting agent for vascular formation | SENJI SEIYAKU K K (JP) | 1997-10-29 | — | — | CN | disclosed |
| CN-1141773-A | Preparation of medicine containing 6-oxo-azitropilidene indole | KALI CHEMIE PHARMA GMBH (DE) | 1997-02-05 | — | — | CN | disclosed |
| CN-1136813-A | Novel synthetic peptide, lung surfactant containing the same and remedy for respiratory distress syndrome | TOKYO TANABE PHARMACEUTICAL CO (JP) | 1996-11-27 | — | — | CN | disclosed |
| CN-1069733-A | 6-OXO-AZA * INDOLES, PROCESS FOR THEIR PRODUCTION, INTERMEDIATE PRODUCTS AND PHARMACEUTICAL APPLICATIONS | KALI CHEMIE PHARMA GMBH (DE) | 1993-03-10 | — | — | CN | disclosed |
| CN-1039026-A | The method for preparing trinucleated 3-oxo-propanenitrile derivatives | ERBA CARLO SPA (IT) | 1990-01-24 | — | — | CN | disclosed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11981753-B2 | Peptide compound and application thereof, and composition containing peptide compound | KISS1R, NPY1R, GLP1R | RNPEP 712/4885SLC7A5 831/4885ALDH1A1 4788/4885 |
| US-20230159453-A1 | INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | VIM, ACE, ACE2 | RNPEP 279/4885SLC7A5 1967/4885ALDH1A1 1895/4885 |
| US-20200172575-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | KISS1R, VIP, NPY1R | RNPEP 311/4885SLC7A5 400/4885ALDH1A1 4326/4885 |
| US-20230150933-A1 | BROAD SPECTRUM ANTIVIRALS AGAINST CORONAVIRUS | SARS1, ZC3HAV1, POLL | RNPEP 452/4885SLC7A5 1182/4885ALDH1A1 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.